Analysis of Busulfan in Plasma by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Abed Pablo, Autumn R. Breaud, William Clarke

Research output: Contribution to journalArticle


Bone marrow transplantation is used to treat particular types of cancers such as lymphoma, leukemia, and multiple myeloma. Appropriate dosing of busulfan during the preparative phase is critical for a successful allograft; if blood concentrations get too high significant liver toxicity can occur, if blood concentrations are too low, then graft-versus-host disease (GVHD) can develop. Busulfan monitoring in blood allows hospitals with the opportunity to provide individualized medicine to patients and improve overall patient outcome. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is an important analytical method for quantification of busulfan in plasma in order to optimize the dose.

Original languageEnglish (US)
Article numbere93
JournalCurrent Protocols in Toxicology
Issue number1
StatePublished - Jun 1 2020


  • bone marrow transplantation
  • busulfan
  • chromatography
  • tandem mass spectrometry
  • therapeutic drug monitoring

ASJC Scopus subject areas

  • Toxicology

Fingerprint Dive into the research topics of 'Analysis of Busulfan in Plasma by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)'. Together they form a unique fingerprint.

  • Cite this